Bharat Biotech

BBIL has established large-scale manufacturing facilities in Hyderabad and Bhubaneswar with a capacity to produce up to 200 million doses of Hillchol, said Executive Chairman Krishna Ella

Bharat Biotech adds ICMR as co-owner of Covaxin patent

The Hyderabad-based biotech company clarified late at night that in the "rush" to develop vaccines and file the necessary patents, BBIL had forgotten to include ICMR's name in the original filings.

Bharat Biotech's Rotovac linked to infant bowel risk; company defends safety: Report

Bharat Biotech's Rotovac vaccine, part of India's immunisation drive, linked to higher infant intussusception risk in a study published in the International Journal of Risk and Safety in Medicine.

Over 30% of Covaxin recipients report 'adverse events' in BHU study. What are the side effects?

Out of 926 participants of the study, around 50 percent complained of infections during the follow-up period, which was dominated by viral upper respiratory tract infections, the research showed.

Bharat Biotech begins clinical trials of TB vaccine on adults in India

Trials to evaluate the safety and immunogenicity of Mtbvac have started with a pivotal safety, immunogenicity and efficacy trial which has been planned to start in 2025, the release said.

Bharat Biotech recalls batch of typhoid vaccine after CDSCO red flag

The TYPBAR vaccine was first in India to get a World Health Organisation Good Manufacturing Practice (WHO-GMP) prequalification certificate

COVID-19 cases cross 10,000 per day but booster vaccination stays sluggish 

Slow public procurement of COVID-19 vaccines has meant that the only way those eligible can avail the booster is by paying at private hospitals, leading to very low demand for precautionary doses despite rising cases.

'Today, I am Satisfied': In a First, PM Modi Talks About Leading Battle Against Covid, Rush to Bring Vaccine

In the 60-minute documentary titled ‘The Vial – India’s Vaccine Story’, PM Modi said the need of the hour was to develop a vaccine and for that, decision-making “could not move at the speed of files”

‘It Would be Foolishness to Assume…' Know the First Thought in PM Modi's Mind as Covid Engulfed World

Talking about the tough decision of imposing a nationwide lockdown to curb the spread of the virus, PM Modi, in History TV18's documentary ‘The Vial – India’s Vaccine Story’, said he was able to educate people that ‘Jaan hai toh jahaan hai’

'India Was the Only Country...': PM Modi Lauds CoWin Game-Changer in ‘The Vial – India’s Vaccine Story’

History TV18’s 60-minute documentary, titled The Vial – India’s Vaccine Story, is the first to feature PM Narendra Modi where he speaks in detail about India’s victory over the Covid-19 pandemic

From Plane to Truck, Car, Boat & Finally on Foot, How Covid-19 Vaccine Reached Remotest Parts of India

Marrying technology with a spirit to eliminate the virus from the country also led to ingenious solutions such as the use of drones to deliver vaccines

Not Just Tough Terrain, Frontline Workers Fought Mindsets for Covid Jab | History TV18 Documentary

‘The Vial – India’s Vaccine Story’ revealed how residents of Malana, a village in Parvati Valley, claim they are the descendants of Alexander the Great and view outsiders --- including health workers --- with suspicion

'Jaan Hai Toh Jahaan Hai': History TV18 Documentary Brings Focus on India's Untold Story of War on Covid

Narrated by actor Manoj Bajpayee, the 60-minute documentary that aired at 8pm on Friday traces India’s journey from deciding to develop a vaccine on its own to becoming the world’s saviour by providing the jabs to several countries

3 lakh doses of intranasal Covid vaccine sent to hospitals: Bharat Biotech's Krishna Ella

He was speaking on the sidelines of an event here at which a bilateral agreement was signed between the University of Wisconsin (UW)-Madison Global Health Institute (GHI) and the Ella Foundation for the establishment of the first-ever UW-Madison One Health Centre in Bengaluru.

Merge state, central drug regulators for better standards: Bharat Biotech chairman

In the past few months, there have been repeated instances of foreign drug regulators raising the red flag against medicines manufactured by Indian pharmaceutical firms

Bharat Biotech's Krishna Ella suggests merging state drugs regulators with central body to ensure 'one quality one standard'

His comments came on Sunday in the backdrop of questions being raised about the quality of Indian drugs over the past few months.

Mansukh Mandaviya launches Bharat Biotech's nasal Covid vaccine

The nasal vaccine -- BBV154 -- had received the Drugs Controller General of India's (DCGI) approval in November for restricted emergency use among adults as a heterologous booster dose.

Indian Pharmaceutical Congress: Bharat Biotech founder bats for incentives, tax breaks for patented products, innovation

"Research linked incentive for Indian companies is very important. I would request the ministry to give tax breaks to any product that is created from patent filed in India. It will inspire entrepreneurs to go for innovation," he said.

MC Exclusive | Bharat Biotech’s intranasal COVID-19 vaccine likely to be available only in corporate hospitals in major cities

Due to lack of rise in demand for booster doses, small private hospitals have showed no interest in procuring the vaccine despite the ease of administration it promises, say industry sources

Ocugen-Bharat Biotech COVID vaccine meets main goals in US trial

The vaccine, sold under brand name Covaxin, showed an immune response in individuals who had not received a COVID vaccine previously as well as those vaccinated with mRNA vaccines by Pfizer Inc and Moderna Inc, meeting its main goals, Ocugen said.

Bharat Biotech’s Covaxin inching closer to US launch plan?

Covaxin was found to be well-tolerated in vaccine-naïve individuals and in individuals previously vaccinated with mRNA vaccines in the US with no vaccine-related serious adverse events, Bharat Biotech’s partner in the country has announced

Biological E, Bharat Biotech together sitting on stockpile of 250 million COVID vaccine doses

According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.

Bharat Biotech's nasal COVID-19 vaccine to be available from today. Here's how you can get it

The COVID-19 vaccine will now be offered to the adults earlier fully vaccinated with Covaxin or Covishield after the government incorporated changes in the CoWin app.

Bharat Biotech's intranasal Covid vaccine approved by govt, to be available on CO-WIN

The nasal vaccine -- BBV154 -- received approval of the Drugs Controller General of India in November for restricted use in an emergency situation for those above 18 as a heterologous booster dose.

Bharat Biotech's nasal vaccine to be available as booster for 18+ as India readies for another pandemic test

The Hyderabad-based Covaxin maker’s nasal vaccine will be introduced on Co-WIN by next week, sources said, adding that the pricing is yet to be decided